Evidence map›Paper›PMID 11036044›Full record

ArticleAntimicrobial agents and chemotherapy2000

Protection against lipopolysaccharide-induced death by fluoroquinolones.

A A Khan, T R Slifer, F G Araujo, Y Suzuki, J S Remington

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2012
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Lack of interaction of fluoroquinolones with lipopolysaccharides.Antimicrobial agents and chemotherapy · 2002
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A A KhanDepartment of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, USA.
T R Slifer
F G Araujo
Y Suzuki
J S Remington

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because fluoroquinolones have an immunomodulatory effect on cytokine production by lipopolysaccharide (LPS)-treated human monocytes, we examined the effect of fluoroquinolones on the survival of mice injected with a lethal dose of LPS. Trovafloxacin (100 mg/kg), ciprofloxacin (250 mg/kg), and tosufloxacin (100 mg/kg) protected 75% (P = 0.0001), 25% (P = 0.002), and 50% (P = 0.002), respectively, of mice against death. The fluoroquinolones significantly reduced serum levels of interleukin-6 and tumor necrosis factor alpha in LPS-treated mice. The protective effects of fluoroquinolones in LPS-induced shock in mice may also occur in humans.

Indexed as

FluoroquinolonesAnimalsAnti-Bacterial AgentsAnti-Infective AgentsCiprofloxacinCytokinesDeathDrug InteractionsLipopolysaccharidesMiceMice, Inbred BALB CMonocytesNaphthyridinesProtective AgentsShock, SepticAnti-Bacterial AgentsAnti-Infective AgentsCiprofloxacinCytokinesFluoroquinolonesLipopolysaccharidesNaphthyridinesProtective Agentstrovafloxacin

Identifiers

PMID11036044
PMCPMC101624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.